Skip to main content

Table 4 Independent Predictors of all-cause and CVD morality among U.S. adults aged 60 and over, NHANES III (1988–1994)

From: Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

  All-cause Mortality CVD Mortality
Risk Factors Aged 60–74 Aged 75 and over Aged 60–74 Aged 75 and over
NAFLD 1.23 (1.07–1.42) 1.12 (0.97–1.29) 1.20 (0.95–1.52) 1.07 (0.90–1.26)
Male 1.41 (1.20–1.65) 1.55 (1.30–1.84) 1.50 (1.20–1.87) 1.51 (1.21–1.87)
Smoker 2.01 (1.70–2.38) 1.27 (0.91–1.77) 2.09 (1.61–2.71) 1.11 (0.66–1.87)
Hypertension 1.45 (1.27–1.67) 1.23 (1.01–1.51) 1.60 (1.26–2.03) 1.24 (0.97–1.60)
Hyperlipidemia 0.96 (0.81–1.13) 1.01 (0.81–1.25) 1.35 (1.01–1.81) 1.21 (0.88–1.66)
Advanced fibrosis 1.53 (1.21–1.93) 1.43 (1.25–1.63) 1.27 (0.88–1.82) 1.37 (1.15–1.64)
History of CVD 2.00 (1.74–2.31) 1.17 (0.94–1.46) 3.59 (2.86–4.49) 1.59 (1.32–1.91)
History of cancer 1.49 (1.24–1.78) 1.15 (0.99–1.33) 1.44 (1.08–1.94) 1.06 (0.90–1.25)
  1. NAFLD was defined as a US FLI score of ≥30 in the absence of any other cause of chronic liver disease
  2. Advance Fibrosis was defined as a NFS of ≥0.676
  3. p < .05